SCHEMBL8285155

SCHEMBL8285155

Cc1cc(NC2CC2)nc2c1c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.47
GSK3B P49841 8/20 0.40
CDK2 P24941 7/20 0.40
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
KDM4E B2RXH2 1/20 0.40
CDK1 P06493 1/20 0.36
AOC3 Q16853 1/20 0.36
GAA P10253 2/20 0.36
HPGD P15428 2/20 0.36
MAPK1 P28482 1/20 0.36
POLB P06746 1/20 0.35
KHK P50053 1/20 0.35
TYK2 P29597 1/20 0.34
CSNK2A2 P19784 2/20 0.34
ALDH1A1 P00352 1/20 0.34
HTT P42858 1/20 0.34
CDK4 P11802 1/20 0.34
CCND1 P24385 1/20 0.34
CCND2 P30279 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5871799 0.88 PDE11A (0.50) PDE11AGSK3BLMNASMN1; SMN2KDM4E
SCHEMBL8286397 0.84 KDM4E (0.49) PDE11AKDM4EHPGDHTTRIPK1
SCHEMBL8285161 0.84 PDE11A (0.47) PDE11AGSK3BLMNASMN1; SMN2KDM4E
SCHEMBL8285163 0.83 POLB (0.50) PDE11AGSK3BLMNASMN1; SMN2KDM4E
SCHEMBL8287116 0.82 PDE11A (0.48) PDE11ALMNASMN1; SMN2KDM4EGAA
SCHEMBL8287107 0.82 PDE11A (0.48) PDE11ALMNASMN1; SMN2KDM4EGAA
SCHEMBL8285218 0.82 PDE11A (0.46) PDE11AGSK3BLMNASMN1; SMN2KDM4E
SCHEMBL8287118 0.82 PDE11A (0.46) PDE11ALMNASMN1; SMN2KDM4EGAA
SCHEMBL8358812 0.81 PDE11A (0.46) PDE11ACDK2LMNASMN1; SMN2GAA
SCHEMBL5871751 0.81 PDE11A (0.48) PDE11AGSK3BLMNASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed